www.mhlw.go.jp/stf/newpage_23815.html
archives
This URL has 1 public saves. The first save was Apr 9, 2026, 06:02 PM and the latest save was Apr 9, 2026, 06:02 PM.
View recent saves on this domain
Latest saved version
新型コロナウイルス治療薬の特例承認について｜厚生労働省
This is the newest public snapshot for this URL and the best place to start reviewing the page.
Source URL
https://www.mhlw.go.jp/stf/newpage_23815.html
About this page
This page announces the exceptional approval of a COVID-19 treatment drug by Japan's Ministry of Health, Labour and Welfare on February 10, 2022. Pfizer's "Paxlovid Pack" (generic name: nirmatrelvir and ritonavir) received special approval under Article 14-3 of the Pharmaceutical Affairs Law. The application was submitted on January 14, 2022, for treating SARS-CoV-2 infections. Additional details are provided in the attached press release and statement from the Minister of Health, Labour and Welfare.
Saved versions
www.mhlw.go.jp/stf/newpage_23815.html web archives are listed here. You can still review the saved screenshot and HTML even if the original page disappears.